BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Influenza
,
Heart
,
Avian flu virus
,
Doxycycline
,
rs4950928
,
MYC
,
T cell differentiation
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
c Rel
Summary
General Info
Curated Studies
Most Correlated Studies
B lymphocytes from germinal centers of conditional c-REL knockouts
Hodgkin and Non-Hodgkin lymphoma cells with doxycyline-induced shRNA knockdown of Rel-B and c-Rel
Splenic CD8 positive T-cells from PKC theta KO and P50 CREL DKO mice stimulated with OVA peptide N4
L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)
L1000 CMAP Lung cancer NCI-H1299 cells with gene overexpression perturbations
Explore Curated Studies Results
Literature
Most Relevant Literature
Negative regulation of FOXP3 expression by c-Rel O-GlcNAcylation.
NF-κB/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Par…
In silico drug discovery for a complex immunotherapeutic target - human c-Rel protein.
NF-κB c-Rel Is Dispensable for the Development but Is Required for the Cytotoxic Function of NK Cell…
c-Rel employs multiple mechanisms to promote the thymic development and peripheral function of regul…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
PCSK9 Inhibitor on ACS Patients With Multivessel Disease and Relatively Low LDL-C Level in Chinese P…
A Study to Assess the Effect of RO4607381 in Patients With Relatively Low Levels of High Density Lip…
Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg Daily and 50 mg …
Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of REL-1017 (d-Methadone)
Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REL-1017 (d-Methadone)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ